Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009217
Chunk: 87

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 87
---
 Shares that are the subject of such    
 contract shall hold such shares as bare trustee for the Company.                                                                             |

| 68 |

| 144.3 | -A | Subject to the Act, the Company may, at its option, cancel B Deferred Shares by way of a reduction 
 of capital for no consideration; and/or                                                            |

| (B) | Pending any such transfer and/or purchase and/or cancellation, the Company may retain any share certificate 
 that may be issued in respect of any of the B Deferred Shares.                                              |

| 145 | C DEFERRED SHARES |

| 145.1 | The following rights and restrictions shall be attached to the C Deferred Shares of £0.00005 each: |

| (A) | As regards income |

The holders of the C Deferred Shares
shall not be entitled to receive any dividend or any other distribution out of the profits of the Company including, without limitation,
any allotment (whether or not fully paid) as a result of the capitalisation of any sum standing to the credit of any share premium account
or of any reserve (whether or not available for distribution) of the Company;

| (B) | As regards voting |

The holders of the C Deferred Shares
shall not be entitled to receive notice of or to attend or speak (either personally or by proxy) at any general meeting of the Company
or to vote (either personally or by proxy) on any resolution to be proposed at any general meeting of the Company and shall be deemed
by virtue of the passing of the resolution adopting these Articles to have irrevocably agreed to any purchase, cancellation and extinguishment
of the C Deferred Shares pursuant to Articles 145.2 and 145.3 below;

| (C) | As              
 regards capital |

The holders of C Deferred Shares
shall on a return of capital in a liquidation, but not otherwise, be entitled to receive the nominal amount paid up or credited as paid
up on such share but only after the holder of each Ordinary Share shall have received (in cash or specie) the amount paid up or credited
as paid up on such Ordinary Share together with an additional payment of £100 per Ordinary Share and the holders of C Deferred
Shares shall be not entitled to any further or other right of participation in the assets or profits of the Company whatsoever;

| (D) | As                          
 regards variation of rights |

| (1) | The rights attached to the C Deferred Shares shall not be deemed to be varied or                                                 
 ab